Evidence map›Paper›PMID 37144016›Full record

ArticleAnnals of gastroenterology

The influence of frailty on perioperative outcomes in patients undergoing surgical resection of liver metastases: a nationwide readmissions database study.

Shane Shahrestani, Madeleine Silverstein, Tania Nasrollahi, Tasha Nasrollahi, Marissa Maas, Chaiss Ugarte, Sujit Kulkarni, Heinz-Josef Lenz, Yuri Genyk

Open access · diamondAbstract read
In one paragraph

Article in Annals of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shane ShahrestaniDepartment of Hepatobiliary Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA (Shane Shahrestani, Madeleine Silverstein, Marissa Maas, Chaiss Ugarte, Sujit Kulkarni, Yuri Genyk).
Madeleine SilversteinDepartment of Hepatobiliary Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA (Shane Shahrestani, Madeleine Silverstein, Marissa Maas, Chaiss Ugarte, Sujit Kulkarni, Yuri Genyk).
Tania NasrollahiCalifornia Northstate University College of Medicine, Elk Grove, CA (Tania Nasrollahi, Tasha Nasrollahi).
Tasha NasrollahiCalifornia Northstate University College of Medicine, Elk Grove, CA (Tania Nasrollahi, Tasha Nasrollahi).
Marissa MaasDepartment of Hepatobiliary Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA (Shane Shahrestani, Madeleine Silverstein, Marissa Maas, Chaiss Ugarte, Sujit Kulkarni, Yuri Genyk).
Chaiss UgarteDepartment of Hepatobiliary Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA (Shane Shahrestani, Madeleine Silverstein, Marissa Maas, Chaiss Ugarte, Sujit Kulkarni, Yuri Genyk).
Sujit KulkarniDepartment of Hepatobiliary Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA (Shane Shahrestani, Madeleine Silverstein, Marissa Maas, Chaiss Ugarte, Sujit Kulkarni, Yuri Genyk).
Heinz-Josef LenzDepartment of Preventative Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California (Heinz-Josef Lenz); USA.
Yuri GenykDepartment of Hepatobiliary Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA (Shane Shahrestani, Madeleine Silverstein, Marissa Maas, Chaiss Ugarte, Sujit Kulkarni, Yuri Genyk).
California Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Liver metastases arise frequently from primary colorectal, pancreatic, and breast cancers. Research has highlighted the patient's frailty status as an important predictor of outcomes, but the literature evaluating the role of frailty in patients with secondary metastatic disease of the liver remains limited. Using predictive analytics, we evaluated the role of frailty in patients who underwent hepatectomy for liver metastases. Methods: We used the Nationwide Readmissions Database from 2016-2017 to identify patients who underwent resection of a secondary malignant neoplasm of the liver. Patient frailty was evaluated using the Johns Hopkins Adjusted Clinical Groups (JHACG) frailty-defining diagnosis indicator. Propensity score matching was performed and Mann-Whitney U testing was used to analyze complication rates. Receiver operating characteristic (ROC) curves were created following creation of logistic regression models for predicting discharge disposition. Results: Frail patients reported significantly higher rates of nonroutine discharges, longer inpatient stays, greater costs, higher rates of acute infection, posthemorrhagic anemia, urinary tract infection (UTI), deep vein thrombosis (DVT), wound dehiscence and readmission, and greater mortality (P<0.05). Predictive models for patient discharge disposition, DVT and UTI demonstrated that the use of frailty status and age improved the area under the ROC curves significantly compared to models using age alone. Conclusions: Frailty was found to be significantly correlated with higher rates of medical complications during inpatient stay following hepatectomy in patients with liver metastasis. The inclusion of patient frailty status in predictive models improved their predictive capacity compared to those using age alone.

Indexed as

frailtyhepatobiliaryLivermetastasisoncology

Identifiers

PMID37144016
PMCPMC10152815
OpenAlexW4372332073

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.